Gremlin1: a BMP antagonist with therapeutic potential in Oncology.
Saved in:
| Title: | Gremlin1: a BMP antagonist with therapeutic potential in Oncology. |
|---|---|
| Authors: | Jin Z; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China., Cao Y; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China. yanshuo.cao@bjmu.edu.cn. |
| Source: | Investigational new drugs [Invest New Drugs] 2024 Dec; Vol. 42 (6), pp. 716-727. Date of Electronic Publication: 2024 Sep 30. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39347850 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Gremlin1: a BMP antagonist with therapeutic potential in Oncology. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jin+Z%22">Jin Z</searchLink>; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Cao+Y%22">Cao Y</searchLink>; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China. yanshuo.cao@bjmu.edu.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228309330%22">Investigational new drugs</searchLink> [Invest New Drugs] 2024 Dec; Vol. 42 (6), pp. 716-727. <i>Date of Electronic Publication: </i>2024 Sep 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309330 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-0646 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676997%22">01676997 </searchLink><i>NLM ISO Abbreviation: </i>Invest New Drugs <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39347850 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10637-024-01474-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 716 Titles: – TitleFull: Gremlin1: a BMP antagonist with therapeutic potential in Oncology. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jin Z – PersonEntity: Name: NameFull: Cao Y IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2024 Dec Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1573-0646 Numbering: – Type: volume Value: 42 – Type: issue Value: 6 Titles: – TitleFull: Investigational new drugs Type: main |
| ResultId | 1 |